I am thinking of buying a ColE1-compatible plasmid to co-express biotin ligase (BirA) in E. coli, with the intention of biotinylating in vivo our Avi-tagged constructs. Whatever we end up buying (or constructing) must be compatible with the use of autoinducing media as well.

The problem is that so far, in every commercially available plasmid I have found, BirA expression is driven from a lac-derived or AraB-derived promoter, and our expression constructs use a T7 promoter. So, in autoinducing media BirA transcription would start simultaneously with that of the T7 RNA pol gene, meaning that the BirA transcripts would have to compete for translation with the onslaught of T7-driven transcripts. I suspect that this would lead to less than ideal levels of biotinylated product, and the problems reported for instance in PMID 22227598 seem to confirm my suspicion.

So, my question is, a) is this really a problem?, and if it is, b) Can it be solved by using a different promoter for BirA coexpression, or should I simply do biotinylation in vitro with purified BirA?

Similar questions and discussions